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Objectives. The aim of our study was to evaluate and compare the results of pancreaticogastrostomy (PG) and pancreaticoje-
junostomy (PJ) after pancreaticoduodenectomy (PD). Methods. Published data of randomized clinical trials (RCTs) comparing
the clinically relevant outcomes of PG versus PJ after PD were analyzed. Two reviewers assessed the quality of each trial and
collected data independently. The Cochrane Collaboration’s RevMan 5.0 software was used for statistical analysis. Proportions
were combined, and the odds ratio (OR) with its 95% CI was used as the eﬀect size estimate. Results. Four RCTs published in
1995 or later were included in this meta-analysis, in which 276 patients underwent PG and 277 patients underwent PJ followed
PD. In the combined results of PG versus PJ, a signiﬁcant diﬀerence in the morbidity of intra-abdominal complications (OR, 0.34;
95% CI, 0.23–0.49; P<0.00001) was found, but no signiﬁcant diﬀerence could be found for pancreatic ﬁstula (OR, 0.69; 95%
CI, 0.42–1.12 , P = 0.13) mortality (OR, 1.09; 95% CI, 0.42–2.83; P = 0.87), recovery with no complications (OR, 1.26; 95% CI,
0.90–1.78; P = 0.18), biliary ﬁstula (OR, 0.55; 95% CI, 0.22–1.35; P = 0.19), or in delayed gastric emptying (OR, 0.55; 95% CI,
0.33–1.01; P = 0.06). Conclusions. Current RCTs suggest that PG is better than PJ for pancreatic reconstruction after PD.
1.Introduction
With dramatic improvement in operative mortality, pancre-
aticoduodenectomy (PD) has become increasingly accepted
as a safe and appropriate operation for selected patients
with periampullary tumors, pancreatic head cancer, benign
neoplasms, and other non-neoplastic conditions such as
chronic pancreatitis [1]. With advances in treatment tech-
niques, the mortality rate of PD has decreased to below
5% in many institutions around the world in recent years
[1–5]. However, even with these advancements in operative
technique and postoperative management, postoperative
morbidity of intra-abdominal complications remains high
even in large series [4]. The most common complications
after PD are pancreatic ﬁstula, delayed gastric emptying,
biliary ﬁstula, and wound infection [6–8]. They often
contribute signiﬁcantly to prolonged hospitalization and
mortality [6]. Leakage from the pancreatic anastomosis
remains the single most important cause of morbidity and
sometimes mortality [1].
Recently, considerable attention has been focused on
reﬁnements in operative technique for PD, especially on the
management of the pancreatic remnant, with the intent to
decrease the incidence of pancreatic ﬁstula. These eﬀorts
include technical modiﬁcations such as the pancreatojejunal
anastomosis technique, the pancreatogastric anastomosis,
and external drainage of the pancreatic duct [5]. Pan-
creaticogastrostomy (PG) and pancreaticojejunostomy (PJ)
have been the most commonly used method of restoring
pancreatioenteric continuity after PD. Some retrospective
studies [9–11] and one RCT [12] have reported lower pan-
creatic ﬁstula rate with PG instead of PJ, and a recent meta-
analysis [13] suggested that the safer means of pancreatic
reconstruction after PD was PG. However, 3 RCTs [14–16]
showed PG and PJ to be similar in regards to pancreatic
ﬁstula rates, and a recent meta-analysis concluded [17] that
PG and PJ were not diﬀerent in terms of pancreatic ﬁstula
rate or overall morbidity rate.
Thus, in order to establish which is the best technique
for pancreatoenteric anastomosis, it is important to identify2 Gastroenterology Research and Practice
the deﬁnition of pancreatic ﬁstula used, before any series
of patients can be compared [1]. To evaluate and compare
the results of PG and PJ after PD, we performed an up-to-
date meta-analysis to PG versus PJ including all RCTs, and
when appropriate and possible, to establish the sources of
heterogeneity in the results.
2.MaterialsandMethods
2.1. Data Sources. We performed a systematic review of the
literature published between 1990 and July 2011. To identify
studies published from 1990 to July 2011, we performed
a comprehensive search of abstracts in the MEDLINE
database, OVID database, Springer database, the Science
Citation Index, and the Cochrane Library database with
use of the following search terms: “pancreaticoduodenec-
tomy,” “pancreaticogastrostomy,” “pancreaticojejunostomy,”
with limitations to Randomized Controlled Trial, Humans.
Reports in any language were eligible for inclusion. To
avoid double counting, two data extractors compared the
articles for participating institutions and inclusion criteria.
Unpublished research was not included.
2.2. Inclusion and Exclusion Criteria. Only RCTs were
included. Any etiology for PD was eligible, and there was
no limitation because of race, gender, or age. Comparator
intervention was considered PG, while control intervention
was considered PJ.
2.3. Statistical Analysis. Two independent reviewers
extracted data by using a specially developed form and
entered it into the freeware program Review Manager
(Version 5.0 for Windows, Cochrane Collaboration, Oxford,
UK, 2008), respectively. The odds ratio (OR) for each trial
was calculated from the number of evaluable patients,
and ORs with their two-sided 95% CIs were used for
dichotomous outcomes as the conﬁrmatory eﬀect size
estimate and test criterion. For continuous variables,
weighted mean diﬀerence (WMD) was calculated with 95%
conﬁdence intervals. In the course of data combination,
heterogeneity was evaluated with the Cochran Q test. The
ﬁxed-eﬀects model and random-eﬀects model were applied.
The hypothesis tests were based on the 95% CIs, and P
values were used for illustration. All P values were two-sided,
and P<0.05 was considered statistically signiﬁcant. To
determine the potential risk bias in the overall results from
the inclusion of studies that violated some of the eligibility
criteria, sensitivity analysis and publication bias analysis
were performed.
3. Results
3.1. Trial and Patient Characteristics. A total of 398 studies
were retrieved, and the process of identifying relevant trials
is shown in Figure 1. Among these 398 studies, 369 were
excluded because of trial design, 29 studies were potentially
appropriateclinicaltrialstobeincludedinthemeta-analysis,
15 were excluded because of absence of randomization, and
9 were excluded RCTs for other reasons. Finally, ﬁve RCTs
Table 1: Characteristics of RCTs Included in the study.
Author Year Total No. Setting AC Operation
Bassi et al.
[15]
2005 151 Single center Adequate PPPD or
PD
Duﬀas et al.
[16]
2005 149 Multicenter Adequate PPPD or
PD or ER
Fern` andez-
Cruz et al.
[12]
2008 108 Single center Adequate PPPD
Yeo et al. [14]1995 145 Single center Adequate PPPD or
PD
Abbreviation: AC = allocation concealment; PPPD = pylorus-preserving
pancreaticoduodenectomy; PD =pancreaticoduodenectomy; ER = extended
resection. ∗PPPD or PD plus resections extended to other organs (colon,
small intestines, mesenteric portal conﬂuence, liver, biliary tree).
were included [12, 14–16], which were all published as full
articles; clinically relevant outcomes for our study could not
be extracted from one of these ﬁve, thus leaving four RCTs
for meta-analysis. Among these 4 studies, there were a total
of 276 patients that underwent PJ and 277 patients that
underwent PJ. The main characteristics of the four included
studies are reported in Table 1.
3.2. Results of Meta-Analysis
3.2.1.MorbidityofIACs. Theintra-abdominalcomplications
(IACs) included pancreatic, biliary, or digestive tract ﬁstula,
intra-abdominal collections (either infected [abscess] or
not), acute pancreatitis, cholangitis; intra-abdominal or
digestive tract hemorrhage, delayed gastric emptying, and
wounddisruption(eitherinfectedornot).Thefourincluded
RCTs involved 553 patients reported IACs. The morbidity
of IACs in PG group and PJ group was 43.1% (119/276)
and 66.1% (183/277), respectively. Meta-analysis showed a
signiﬁcantdiﬀerenceinmorbidityofIACsbetweenPGgroup
and PJ group (OR, 0.34; 95% CI, 0.23–0.49; P<0.00001)
(Figure 2).
3.2.2. Pancreatic Fistula. The included RCTs reported on
pancreatic ﬁstula. The rate of pancreatic ﬁstula in the PG
groupandPJgroupwas12.0%(33/276)and16.3%(45/277),
respectively. Meta-analysis showed no signiﬁcant diﬀerence
in pancreatic ﬁstula between PG and PJ group (OR, 0.69;
95% CI, 0.42–1.12; P = 0.13) (Figure 3).
3.2.3. Mortality. Three included RCTs involving 408 patients
reported the mortality. The mortality of PG group and PJ
group was 4.9% (10/203) and 3.9% (8/205), respectively.
Meta-analysis showed no signiﬁcant diﬀerence in mortality
between PG and PJ group (OR, 1.09; 95% CI, 0.42–2.83;
P = 0.87) (Figure 4).
3.2.4. Recovery with No Complications. Four included RCTs
including 553 patients reported recovery with no compli-
cations. The rate of recovery with no complications in
PG group and PJ group was 62.0% (171/276) and 57.0%
(158/277) respectively. Meta-analysis showed no signiﬁcantGastroenterology Research and Practice 3
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Figure 1: QUOROM ﬂow diagram of included and excluded studies.
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Figure 2: Forest plot of morbidity of IACs between PG and PJ.
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Figure 3: Forest plot of pancreatic ﬁstula between PG and PJ.
diﬀerence in pancreatic ﬁstula between PG and PJ group
(OR, 1.26; 95% CI, 0.90–1.78; P = 0.18) (Figure 5).
3.2.5. Biliary Fistula. Biliary ﬁstula was deﬁned as bile in
the drain ﬂuid from the subhepatic drain (or an operatively
placed drain or a subsequently placed percutaneous drain)
with the level of total bilirubin exceeding the upper limit
of normal. 4 included RCTs including 553 patients reported
biliary ﬁstula. The rate of biliary ﬁstula in PG group and
PJ group was 2.5% (7/276) and 4.7% (13/277), respectively.
Meta-analysis showed no signiﬁcant diﬀerence in biliary
ﬁstula between PG and PJ group (OR, 0.55; 95% CI, 0.22–
1.35; P = 0.19) (Figure 6).
3.2.6. Delayed Gastric Emptying. Delayed gastric emptying
(DGE) was deﬁned when the nasogastric tube was main-
tained for ten or more days, combined with one or more
of the following: vomiting after removal of nasogastric tube,4 Gastroenterology Research and Practice
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Figure 4: Forest plot of mortality between PG and PJ.
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Figure 5: Forest plot of recovery with no complications between PG and PJ.
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Figure 6: Forest plot of biliary ﬁstula between PG and PJ.
reinsertion of nasogastric tube, or failure to progress with
oral feeding. Three included RCTs involving 404 patients
reporteddelayedgastricemptying.Therateofdelayedgastric
emptying in PG group and PJ group was 10.3% (20/195)
and 16.3% (34/209), respectively. Meta-analysis showed no
signiﬁcant diﬀerence in delayed gastric emptying between
PG and PJ group (OR, 0.55; 95% CI, 0.33–1.01; P = 0.06)
(Figure 7).
3.3. Sensitivity Analysis and Publication Bias. Sensitivity
analysis and publication bias estimates were performed
to determine statistically signiﬁcant results. For intra-
abdominal complications (IACs) between PG group and PJ
group, combined ORs were calculated with a ﬁxed-eﬀects
model and a random-eﬀects model, and the results were
compared. The OR with a ﬁxed-eﬀects model was 0.34 (95%
CI, 0.23–0.49; P<0.00001); moreover, because statistically
signiﬁcant data are more likely to be published and the
ﬁndings of the present review were mostly positive, our
meta-analysis was likely inﬂuenced very little by publication
bias. However, because of the small numbers of randomized
controlled trials available, more detailed stratiﬁcation com-
parisons could not make, which could have inﬂuenced the
validity of our study to some extent.
4. Discussion
To reduce the incidence of postoperative complications, a
variety of techniques [18]a sw e l la sp h a r m a c o l o g i cp r o p h y -
lactic approaches [19, 20] have been used and evaluated over
the years in the management of the pancreatic remnant fol-
lowing PD. Pancreatic anastomosis leakage remains a majorGastroenterology Research and Practice 5
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Figure 7: Forest plot of delayed gastric emptying between PG and PJ.
cause of postoperative morbidity after PD, and it contributes
signiﬁcantly to operative mortality. Pancreatoenteric anasto-
motic failure is one of the major causes of morbidity because
of delayed gastric emptying, pancreatic ﬁstula, and wound
infection; pancreatic ﬁstula can also lead to hemorrhage
(intra-abdominal and/or into the digestive tract), leakage
(biliary and/or digestive tract), intra-abdominal infection,
wound disruption (infected or no), and even death. The
most common techniques for reconstruction of pancreatic
gastrointestinal continuity after PD involve a pancreatico-
enteric anastomosis, usually either PJ or PG. The best
technique for pancreatic anastomosis is still a challenge for
the pancreatic surgeon. The pancreatojejunal anastomosis
is carried out either as an end-to-end anastomosis with
invagination of the pancreatic stump into the jejunum or
as an end-to-side anastomosis with or without duct-to-
mucosa suturing [21]. The pancreatogastric anastomosis is
performed to the gastric lumen through either the gastric
stump or through an anterior wall gastrostomy (in the case
of pylorus-preserving PD).
The present meta-analysis showed that PG is better than
PJ for pancreatic reconstruction after PD, because PG has
lower morbidity of intra-abdominal complications than PJ
(P<0.00001), while the two techniques of anastomosis were
not diﬀerent in terms of pancreatic ﬁstula rate (P = 0.13),
mortality (P = 0.87), recovery with no complications rate
(P = 0.18), biliary ﬁstula rate (P = 0.19), and delayed gastric
emptying rate (P = 0.06).
The technique of PG has several potential advantages
over PJ. First, the PG anastomosis can be performed easily,
because the posterior wall of the stomach lies immedi-
ately anterior to the mobilized pancreatic remnant and is
usually wider than the transected pancreas. Second, with
PG, the pancreatic exocrine secretions enter the potentially
acidic gastric environment, precluding digestive damage of
the pancreatoenteric anastomosis by activated proteolytic
enzymes. In contrast with PJ, the activation of pancreatic
exocrine secretions can occur more easily in the presence of
intestinal enterokinase and bile. Third, PG avoids the long
jejunal loop where pancreatobiliary secretions accumulate
during the early postoperative period. Fourth, postoperative
gastric decompression can provide constant removal of
pancreatic and gastric secretions avoiding accumulation and
thus tension on the anastomosis. Fifth, PG anastomosis
reduces the number of anastomoses in a single loop of
retained jejunum, which potentially decreases the likelihood
ofloopkinking.Thedecreasedmorbidityofintra-abdominal
complications for PG may be the result of the aforemen-
tionedtheoreticaladvantages.Publishedstudieshavefavored
PG over PJ [12, 22] although these studies are limited by
their small patient populations.
It is generally accepted that compared to a ﬁbrotic
pancreatic remnant, a soft and fragile pancreatic remnant
frequently results in a high pancreatic anastomosis leakage
rate[23].Therearemanyfactorswhichcanleadtopancreatic
anastomosis leakage (pancreatic ﬁstula), including pancre-
atic factors (pancreatic texture, original pathology, blood
supply to the pancreas remnant, pancreatic juice output,
pancreatic duct size), patient factors (age, gender, level
of preoperative jaundice, comorbid illness), and operative
factors (operation time, blood loss, type of anastomosis,
stenting of pancreatic duct) [1, 24–27]. Among these factors,
the main factors include pancreatic texture [1, 27–29],
pancreatic stump blood supply, pancreatic duct size [1, 29],
and pancreatic juice output [27, 30]. All RCTs which were
included in our study reported diverse factors (pancreatic
factors, patient factors, and operation factors) which were
diﬀerent between the PG group and the PJ group. For
pancreatic ﬁstula, the present study showed no signiﬁcant
diﬀerence in two groups (P = 0.13). Although there is
heterogeneity between the analyzed RCTs, all RCTs were
conducted in specialized centers by highly experienced
surgeons, and the surgical care is likely to be similar among
studies. Regarding methodological quality, we consider our
analyses to be relevant [31].
The results of this meta-analysis are in line with research
from McKay et al. [13] and are partly similar with Wente et
al. [17]. However, our meta-analysis has some limitations.
First, due to the lack of speciﬁc information in the original
papers, we cannot perform a subgroup analysis according
to patient age and the etiology of PD; thus, it is unclear
whether the advantage of PG is potentially applicable to all
subgroups of patients. Second, the reported technique for
PD in each RCT was variable with conventional PD, PPPD,
or PD plus extended resection (Figure 1). Diﬀerent operative
procedures could lead to diﬀerent complications. Third,
other factors, such as presenting symptoms, preoperative
blood parameters, the presence of comorbid illness, and
preoperative biliary drainage, could inﬂuence the frequency
or type of morbidity. Fourth, the deﬁnition for pancreatic6 Gastroenterology Research and Practice
ﬁstula also varied between RCT, with only one [14], utilizing
the ISGPF criteria [24], which could inﬂuence our study.
Fifth, this meta-analysis included only 553 patients and 4
R C T s ,a n dat y p eI Ie r r o rm a yb ep o s s i b l e .
In conclusion, the evidence from this formal meta-
analysis suggests that PG is better than PJ for pancreatic
reconstruction after PD. PG can provide an adequate recon-
struction for pancreaticoenteric continuity following PD.
Future large-scale, high-quality, multicenter trials are still
required to clarify the issues of PG reconstruction following
PD. For future experiment on PD, the question for the
management of the pancreatic remnant must be addressed
in the future.
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